Acxiom, Ambac Financial Group and Jackson Hewitt Tax Service lead small-cap percentage losers
Acxiom Corp. (Nasdaq:ACXM), Ambac Financial Group, Inc. (Nasdaq:AKT) and Jackson Hewitt Tax Service Inc. (Nasdaq:JTX) are among the biggest percentage losers in Thursday's trading among companies with market capitalizations under $1 billion.
Also included among the results: Alyst Acquisition Corp. (Nasdaq:AYA), Celldex Therapeutics Inc. (Nasdaq:CLDX), Encore Bancshares Inc. (Nasdaq:EBTX), Republic Airways Holdings Inc. (Nasdaq:RJET), Chemgenex Pharm Depository Receipt (Nasdaq:CXSP) and Old Second Bancorp Inc. (Nasdaq:OSBC).
[ More » ]
Also included among the results: Alyst Acquisition Corp. (Nasdaq:AYA), Celldex Therapeutics Inc. (Nasdaq:CLDX), Encore Bancshares Inc. (Nasdaq:EBTX), Republic Airways Holdings Inc. (Nasdaq:RJET), Chemgenex Pharm Depository Receipt (Nasdaq:CXSP) and Old Second Bancorp Inc. (Nasdaq:OSBC).
Dress Barn, Spectrum Pharmaceuticals and A Power Energy Generation Systems lead small-cap volume in pre-market
Dress Barn Inc. (Nasdaq:DBRN), Spectrum Pharmaceuticals Inc. (Nasdaq:SPPI) and A Power Energy Generation Systems Ltd. (Nasdaq:APWR) are among the most actively traded companies in Thursday's trading among companies with market capitalizations under $1 billion.
Also included among the results: Century Aluminum Co. (Nasdaq:CENX), IMAX Corp. (Nasdaq:IMAX), Celldex Therapeutics Inc. (Nasdaq:CLDX), AgFeed Industries Inc. (Nasdaq:FEED), Canadian Solar Inc. (Nasdaq:CSIQ) and Healthways Inc. (Nasdaq:HWAY).
[ More » ]
Also included among the results: Century Aluminum Co. (Nasdaq:CENX), IMAX Corp. (Nasdaq:IMAX), Celldex Therapeutics Inc. (Nasdaq:CLDX), AgFeed Industries Inc. (Nasdaq:FEED), Canadian Solar Inc. (Nasdaq:CSIQ) and Healthways Inc. (Nasdaq:HWAY).
National Penn Bancshares, Nelnet and Molecular Insight Pharmaceuticals lead small-cap percentage gainers
National Penn Bancshares Inc. (Nasdaq:NPBC), Nelnet Inc. (Nasdaq:NNI) and Molecular Insight Pharmaceuticals Inc. (Nasdaq:MIPI) are among the biggest percentage gainers in Thursday's trading among companies with market capitalizations under $1 billion.
Also included among the results: ChinaCast Education Corp. (Nasdaq:CAST), Wonder Auto Technology Inc. (Nasdaq:WATG), Fuel Systems Solutions Inc. (Nasdaq:FSYS), Celldex Therapeutics Inc. (Nasdaq:CLDX), Fuqi International Inc. (Nasdaq:FUQI) and Talbots Inc. (Nasdaq:TLB).
[ More » ]
Also included among the results: ChinaCast Education Corp. (Nasdaq:CAST), Wonder Auto Technology Inc. (Nasdaq:WATG), Fuel Systems Solutions Inc. (Nasdaq:FSYS), Celldex Therapeutics Inc. (Nasdaq:CLDX), Fuqi International Inc. (Nasdaq:FUQI) and Talbots Inc. (Nasdaq:TLB).
Russell 2000 Small Caps Lead the Indices
Small Caps making up the Russell 2000 are up 3.76% as of reporting at 1:30 P.M. Eastern today. This leads the Dow Jones Industrials, up 2.85%, and the Nasdaq, up 2.62%.
Leading small cap gainers today include U-Store-It Trust (NYSE:YSI), up 19.6%, which owns and operators self storage facilities in the United States on news of its establishment of a self storage network to include the company owned 386 facilities as well as 150 locations run with third-party partners, and plans for 250 more in the works to join the network.
Other small cap leaders include MarineMax (NYSE:HZO) up 22.64%; American Axle (NYSE:AXL) up 22.06%; Russ Berrie & Co (NYSE:RUS) up 19.6%, Celldex Therapeutics (Nasdaq:CLDX), up 32.1%; Green Plains Renewable Energy (Nasdaq:GPRE), up 32.7%.
Readers from Friday's edition will recall that GPRE was a market leader before the weekend as well. It closed on Friday at $4.40 after flirting with the $4.50 mark having opened at $3.41 in the morning. In Monday's open GPRE gapped up to start at $5.00 and as of press time is at $5.84, up 32.7% for the day.
Since the opening bell after Memorial Day, GPRE is up 107%. GPRE produces, distributes, and markets ethanol and related products in the United States. GPRE was founded in Omaha, Nebraska in 2006. GPRE recently purchased two ethanol plants previously owned by VeraSun Energy.
*****Both the Nasdaq and the S&P 500 are hitting new recovery rally highs today. Part of the reason for today's strength is the better than expected construction numbers released this morning.
The 0.8% gain in construction spending for April was the biggest gain in nearly a year. And it was far better than economists' expectations of a 1.5% drop.
This is how it will be during an economic recovery. There will be wild swings in data. Don't be surprised if construction contracts for May, and then picks up in June. Or vice versa. It really could go either way. And that won't necessarily be bad news.
Of course, it would be great to see the numbers continue to steadily improve. But that's not the way it works when an economy is recovering from the type of shocks the U.S. economy has received.
*****General Motors (NYSE:GM) ended the suspense. As expected, it filed for bankruptcy protection this morning. It's the 4th largest bankruptcy filing in US history. GM has $82 billion in assets and $172 billion in debt.
GM stock is up +20% in the early going today. I want to know why. My guess is that shorts are covering their positions. Still, I don't know why. It's expected that GM common stock will be cancelled as part of the bankruptcy proceedings.
That would mean that shorts don't have to cover their position. However, shorts may continue to incur borrowing fees from the shares they have sold. In order to be completely free of the trade, maybe covering is the way to go.
*****I've read that GM may resume trading as a new public company in 6-12 months. I don't see why it should take that long. A motivated bankruptcy judge ought to be able to deal with GMs debt faster than that.
But I will say that, depending on the terms of the bankruptcy, GM stock should be a good buy when it comes public again. GM will be stripped of one of its major stumbling blocks - pension benefits.
It's estimated that pension benefits add $1,500 in expenses for GM on each car it builds. Obviously, in today's competitive environment, that's insurmountable.
However, once these costs are gone, and GM can operate with leaner margins, the stock could be a good buy.
*****SmallCapInvestor PRO readers are enjoying their second +100% gain this year. The stock is Genco Shipping (NYSE:GNK) and it was recommended on April 9 at $14.20 a share. Please do not by the stock now. We will be taking our profits on it in the near future.
We're holding our other triple digit winner. This domestic oil and gas stock is up +130%. But the strength in oil prices means that there should be more gains coming. Look to this sector to continue providing winning small caps in the months to come.
I'm getting ready to increase our exposure to China in SmallCapInvestor PRO. The two Chinese stocks in the portfolio now are up, and China is the best growth story in the world right now (indeed, some analysts and economists are calling for China, not the U.S., to lead us to recovery). For more on SmallCapInvestor PRO, please please click HERE.
*****Graham Corp (AMEX:GHM) reported earnings on Friday. And they were not very good. The stock has lost nearly $3 over the past few days. That's plenty for me. If you bought Graham on my recommendation in Daily Profit, it is now time to take your profits. I hope you did well.
[ More » ]
Leading small cap gainers today include U-Store-It Trust (NYSE:YSI), up 19.6%, which owns and operators self storage facilities in the United States on news of its establishment of a self storage network to include the company owned 386 facilities as well as 150 locations run with third-party partners, and plans for 250 more in the works to join the network.
Other small cap leaders include MarineMax (NYSE:HZO) up 22.64%; American Axle (NYSE:AXL) up 22.06%; Russ Berrie & Co (NYSE:RUS) up 19.6%, Celldex Therapeutics (Nasdaq:CLDX), up 32.1%; Green Plains Renewable Energy (Nasdaq:GPRE), up 32.7%.
Readers from Friday's edition will recall that GPRE was a market leader before the weekend as well. It closed on Friday at $4.40 after flirting with the $4.50 mark having opened at $3.41 in the morning. In Monday's open GPRE gapped up to start at $5.00 and as of press time is at $5.84, up 32.7% for the day.
Since the opening bell after Memorial Day, GPRE is up 107%. GPRE produces, distributes, and markets ethanol and related products in the United States. GPRE was founded in Omaha, Nebraska in 2006. GPRE recently purchased two ethanol plants previously owned by VeraSun Energy.
*****Both the Nasdaq and the S&P 500 are hitting new recovery rally highs today. Part of the reason for today's strength is the better than expected construction numbers released this morning.
The 0.8% gain in construction spending for April was the biggest gain in nearly a year. And it was far better than economists' expectations of a 1.5% drop.
This is how it will be during an economic recovery. There will be wild swings in data. Don't be surprised if construction contracts for May, and then picks up in June. Or vice versa. It really could go either way. And that won't necessarily be bad news.
Of course, it would be great to see the numbers continue to steadily improve. But that's not the way it works when an economy is recovering from the type of shocks the U.S. economy has received.
*****General Motors (NYSE:GM) ended the suspense. As expected, it filed for bankruptcy protection this morning. It's the 4th largest bankruptcy filing in US history. GM has $82 billion in assets and $172 billion in debt.
GM stock is up +20% in the early going today. I want to know why. My guess is that shorts are covering their positions. Still, I don't know why. It's expected that GM common stock will be cancelled as part of the bankruptcy proceedings.
That would mean that shorts don't have to cover their position. However, shorts may continue to incur borrowing fees from the shares they have sold. In order to be completely free of the trade, maybe covering is the way to go.
*****I've read that GM may resume trading as a new public company in 6-12 months. I don't see why it should take that long. A motivated bankruptcy judge ought to be able to deal with GMs debt faster than that.
But I will say that, depending on the terms of the bankruptcy, GM stock should be a good buy when it comes public again. GM will be stripped of one of its major stumbling blocks - pension benefits.
It's estimated that pension benefits add $1,500 in expenses for GM on each car it builds. Obviously, in today's competitive environment, that's insurmountable.
However, once these costs are gone, and GM can operate with leaner margins, the stock could be a good buy.
*****SmallCapInvestor PRO readers are enjoying their second +100% gain this year. The stock is Genco Shipping (NYSE:GNK) and it was recommended on April 9 at $14.20 a share. Please do not by the stock now. We will be taking our profits on it in the near future.
We're holding our other triple digit winner. This domestic oil and gas stock is up +130%. But the strength in oil prices means that there should be more gains coming. Look to this sector to continue providing winning small caps in the months to come.
I'm getting ready to increase our exposure to China in SmallCapInvestor PRO. The two Chinese stocks in the portfolio now are up, and China is the best growth story in the world right now (indeed, some analysts and economists are calling for China, not the U.S., to lead us to recovery). For more on SmallCapInvestor PRO, please please click HERE.
*****Graham Corp (AMEX:GHM) reported earnings on Friday. And they were not very good. The stock has lost nearly $3 over the past few days. That's plenty for me. If you bought Graham on my recommendation in Daily Profit, it is now time to take your profits. I hope you did well.
Celldex Therapeutics, US Global Investors and Fauquier Bankshares lead small-cap percentage gainers
Celldex Therapeutics Inc. (Nasdaq:CLDX), US Global Investors Inc. (Nasdaq:GROW) and Fauquier Bankshares Inc. (Nasdaq:FBSS) are among the biggest percentage gainers in Monday's trading among companies with market capitalizations under $1 billion.
Also included among the results: Kirklands Inc. (Nasdaq:KIRK), StealthGas Inc. (Nasdaq:GASS), Amerigon Inc (Nasdaq:ARGN), I-Flow Corp. (Nasdaq:IFLO), CPI Corp. (Nasdaq:CPY) and CPI International Inc. (Nasdaq:CPII).
[ More » ]
Also included among the results: Kirklands Inc. (Nasdaq:KIRK), StealthGas Inc. (Nasdaq:GASS), Amerigon Inc (Nasdaq:ARGN), I-Flow Corp. (Nasdaq:IFLO), CPI Corp. (Nasdaq:CPY) and CPI International Inc. (Nasdaq:CPII).
Paragon Shipping, Crawford and Dycom Industries lead small-cap percentage gainers
Paragon Shipping Inc. (Nasdaq:PRGN), Crawford Ord Shs Class B (Nasdaq:CRD.B) and Dycom Industries Inc. (Nasdaq:DY) are among the biggest percentage gainers in Wednesday's trading among companies with market capitalizations under $1 billion.
Also included among the results: Nymagic Inc. (Nasdaq:NYM), North American Energy Partners Inc. (Nasdaq:NOA), VanceInfo Technologies Inc. (Nasdaq:VIT), Celldex Therapeutics Inc. (Nasdaq:CLDX), Optimer Pharmaceuticals Inc. (Nasdaq:OPTR) and Susser Holdings Corp. (Nasdaq:SUSS).
InterMune, DryShips and John B San Filippo & Son lead small-cap percentage gainers
InterMune Inc. (Nasdaq:ITMN), DryShips Inc. (Nasdaq:DRYS) and John B San Filippo & Son (Nasdaq:JBSS) are among the biggest percentage gainers in Tuesday's trading among companies with market capitalizations under $1 billion.
Also included among the results: Intersections Inc. (Nasdaq:INTX), HSN Inc. (Nasdaq:HSNI), M I Homes Inc. (Nasdaq:MHO), Celldex Therapeutics Inc. (Nasdaq:CLDX), Tessera Technologies (Nasdaq:TSRA) and Infinera Corp. (Nasdaq:INFN).
[ More » ]
Also included among the results: Intersections Inc. (Nasdaq:INTX), HSN Inc. (Nasdaq:HSNI), M I Homes Inc. (Nasdaq:MHO), Celldex Therapeutics Inc. (Nasdaq:CLDX), Tessera Technologies (Nasdaq:TSRA) and Infinera Corp. (Nasdaq:INFN).
Celldex Therapeutics receives $10M milestone payment
Celldex Therapeutics, Inc. (Nasdaq:CLDX) said today that it received a $10 million milestone payment from an affiliate of Paul Capital Healthcare. The payment was triggered by the market launch of Rotarix in the United States, which is marketed worldwide by GlaxoSmithKline (NYSE:GSK).
Shares were halted ahead of the opening bell. For detailed price information and news stories on Celldex Therapeutics, click CLDX.
